Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studies

Glioblastoma (GBM) is a malignant brain tumour with a dismal prognosis, despite best treatment by surgical resection, radiation therapy (RT) and chemotherapy with temozolomide (TMZ). Nanoparticle (NP) therapy is an emerging consideration due to the ability of NPs to be formulated and cross the blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Victor M., Jue, Toni Rose, McDonald, Kerrie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584621/
https://www.ncbi.nlm.nih.gov/pubmed/33097778
http://dx.doi.org/10.1038/s41598-020-75372-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584621/
https://www.ncbi.nlm.nih.gov/pubmed/33097778
http://dx.doi.org/10.1038/s41598-020-75372-3

Ejemplares similares